An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C)

NCT05112965 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: Atezolizumab
DRUG: Bevacizumab
DRUG: Pemetrexed
DRUG: Paclitaxel
DRUG: Enzalutamide

Sponsor

Hoffmann-La Roche